Medications, AstraZeneca Bets on Clinical Research Made in Italy
12 Articles
12 Articles
The company invests 66 million, with the co-financing of Mimit and Fondazione Tech and Biomedical: involved 200 health centers and structures to test the new therapies with an impact of 180 million
AstraZeneca announces an investment programme of 66.2 million euros in Italy over the next 3 years, in an international context characterized by a growing competition to attract investments, skills and research activities. The initiative is also implemented thanks to the co-financing of 20 million euros of the Research and Development Fund [...]
Calabria News
AstraZeneca announces an investment programme of 66.2 million euros in Italy over the next 3 years. The initiative, also implemented thanks to the co-financing of 20 million euros of the Fund for Research and Development [...] L'articolo AstraZeneca, in Italia program for investments in research from 66.2 million euros in 3 years comes from Calabria News.
Al Mimit AstraZeneca announcement: investments for research in Italy from 66.2 million euros in the next three years This article AstraZeneca launches the investment plan for Italy, involved 200 centers comes from LaPresse
In Rome the comparison between institutions, industry and the world of research on the future of Life Sciences. AstraZeneca announces 66.2 million euros of investments in Italy over the next three years, with 20 million public co-financing through the Tech and Biomedical Foundation. Over 200 centers involved The post Clinical Research, Italy accelerates: 66 million euros to strengthen innovation and competitiveness appeared first on Daily Health.
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
